SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables)

3 Months Ended

Jun. 27, 2020

Segment Reporting [Abstract]

Selected Information by Business Segment

Selected information by reportable segment is presented below:

	Three Months Ended
(In thousands)	June 27, 2020		June 29, 2019
Net revenues
Plasma	$	68,715	$	110,763
Blood Center	79,314		77,996
Hospital	45,571		47,187
Net revenues by business unit	193,600		235,946
Service (1)	5,082		4,866
Effect of exchange rates	(3,105)		(2,361)
Net revenues	$	195,577	$	238,451
(1) Reflects revenue for service, maintenance and parts

	Three Months Ended
(In thousands)	June 27, 2020		June 29, 2019
Segment operating income
Plasma	$	36,350	$	53,725
Blood Center	38,745		37,719
Hospital	17,783		18,916
Segment operating income	92,878		110,360
Corporate expenses (1)	(65,062)		(61,703)
Effect of exchange rates	711		2,769
Impairment of assets and other related charges	(964)		(51,166)
Deal amortization	(8,263)		(5,974)
PCS2 accelerated depreciation and related costs	(1,542)		(5,528)
Restructuring and turnaround costs	(4,000)		(2,027)
European Medical Device Regulation costs and other	(753)		(33)
Transaction costs	(1,290)		—
Operating income (loss)	$	11,715	$	(13,302)
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.

Schedule of Revenues by Product Line and Geographic Regions

Management reviews revenue based on the reportable segments noted above. Although these reportable segments are primarily product-based, they differ from the Company’s product line revenues for Plasma products and services and Blood Center products and services. Specifically, the Blood Center reportable segment includes plasma products utilized for collection in blood centers primarily for transfusion purposes. Additionally, product line revenues also include service revenues which are excluded from the reportable segments.

Net revenues by product line are as follows:

	Three Months Ended
(In thousands)	June 27, 2020		June 29, 2019
Plasma products and services	$	88,713	$	129,745
Blood Center products and services	60,667		59,907
Hospital products and services	46,197		48,799
Net revenues	$	195,577	$	238,451

Net revenues generated in the Company's principle operating regions on a reported basis are as follows:

	Three Months Ended
(In thousands)	June 27, 2020		June 29, 2019
United States	$	111,009	$	156,375
Japan	16,831		15,467
Europe	43,019		36,753
Asia	22,384		28,641
Other	2,334		1,215
Net revenues	$	195,577	$	238,451